Viruses that replicate in the human respiratory mucosa without infecting systemically can cause significant mortality and morbidity and are important public health concerns, wrote a group of health experts, including Dr. Anthony S. Fauci.
Because these viruses, including influenza A, SARS-CoV-2, endemic coronaviruses, RSV, and many other "common cold" viruses, generally do not elicit complete and durable protective immunity by themselves, they have not to date been effectively controlled by licensed or experimental vaccines.
Next-generation Respiratory Virus Vaccines Need Innovation
Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
Low-dose computed tomographic scan rates and mammography rates below expected during March 2021 to February 2022
COVID-19 Vaccine Primary Series Coverage 76 Percent in Adults 60 Years and Older
Primary series coverage by end of 2022 was below the 100 percent target set for at-risk populations
COVID-19 Leading Cause of Death for U.S. Children, Young People
COVID-19 was among the 10 leading causes of death in CYP aged 0 to 19 during Aug. 1, 2021, to July 31, 2022
mRNA COVID-19 Vaccines Not Tied to Increases in Guillain-Barré Syndrome
However, the Janssen COVID-19 vaccine was associated with increased risk at 21 and 42 days postvaccination